Fairvalue-Calculator Fairvalue-Calculator
EN DE

CV Sciences, Inc (CVSI) Fair Value & Analysis

Healthcare · US · Market cap $4.1M

Price$0.0220
Fair Value$0.0400
Upside+81.8%
Quality95/100
Evidence: Low Range $0.0300 – $0.0500

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

CV Sciences, Inc (CVSI) currently trades at $0.0220, while our model-based Fair Value estimate is $0.0400 — implying the stock looks roughly 81.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is CV Sciences, Inc (CVSI) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.0400 versus a price of $0.0220 — about +82% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CVSI?
Our 21-model fair value for CV Sciences, Inc is $0.0400 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.0220.
What is the quality score of CVSI?
CV Sciences, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.